The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company’s strategic commitment to the ...
Henry Schein has received a strategic investment of $250 million from KRR, giving the global investment firm a 12% stake in the company, with the option to purchase additional shares ...
Zacks.com on MSN13d
HSIC Stock Might Rise Following the Acquisition of AcentusHenry Schein, Inc. HSIC recently completed the acquisition of substantially all of the assets of Acentus, a national medical ...
BOSTON and NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare ...
Hosted on MSN1mon
HSIC Stock Likely to Gain From Its Latest Acquisition of AcentusAfter the transaction is closed, Acentus’ founders — Brett Carroll, Todd Cianfrocca, Greg Duvall and Julio Valdivia — will join Henry Schein. For investors’ information, Acentus has annual ...
Henry Schein shares up on strategic investment from KKR, management appointments, share buyback, and preliminary results.
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced it has completed the ...
Acentus Founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein, bringing their expertise and experience in the product category and the healthcare industry.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback